Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2022

Risk-adapted strategy in HR+/HER2 negative early breast cancer

Escalating strategies over standard of care as adjuvant treatment therapy in HR+HER2- EBC: Where do we stand?

Date

02 Dec 2022

Session

Risk-adapted strategy in HR+/HER2 negative early breast cancer

Topics

Tumour Site

Breast Cancer

Presenters

Valentina Guarneri

Authors

V. Guarneri

Author affiliations

  • Department Of Surgery, Oncology And Gastroenterology Dept., University of Padua, 35122 - Padova/IT

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Q&A and discussion

Presenter: Suzette Delaloge

Session: Risk-adapted strategy in HR+/HER2 negative early breast cancer

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.